Candice Horbacz
The European Union’s proposed revision of the Tobacco Excise Directive (TED) has ignited a significant debate across Brussels and national capitals, raising fundamental questions about the delicate balance between EU harmonization efforts and the sovereign tax policies of its Member States. While the pursuit of a frictionless Single Market is a cornerstone of European integration, critics argue that an overreach in policy decisions from Brussels, particularly in sensitive areas like taxation, risks undermining national autonomy and could inadvertently harm diverse Member State interests.
At its core, tax policy is a powerful expression of national sovereignty. Governments are entrusted with the responsibility of deciding who to tax, the extent of that taxation, and how to allocate the resulting revenue. These decisions are deeply intertwined with the preferences of their electorates, the unique economic conditions prevalent in each jurisdiction, and the specific public health challenges they face. The EU undeniably plays a crucial role when disparities in national tax systems create tangible distortions of competition within the Single Market, ensuring a level playing field for businesses and consumers alike. However, a meaningful distinction exists between harmonizing tax rules to facilitate commerce and harmonizing tax rates to advance a particular social policy. It is at this juncture that the proposed TED revision faces its most rigorous scrutiny. If tax differences genuinely impede cross-border trade, EU intervention can be justified. Yet, if such harmonization begins to constrain Member States’ ability to implement diverse public health strategies tailored to their specific populations, the rationale for EU-level intervention becomes considerably weaker. The suggested revision of the TED vividly illustrates this complex distinction, pushing the boundaries of EU competence and national prerogative.
The Proposed Revision: What’s on the Table?
The European Commission (EC) officially put forward its comprehensive update to the TED in July 2025, asserting that the existing legislative framework, which has seen little amendment since its last update, no longer adequately reflects the rapid innovation and evolution within the tobacco and nicotine markets. The EC’s proposal aims to broaden the scope of EU minimum taxation significantly, extending it to a range of novel products including e-cigarette liquids, heated tobacco products, nicotine pouches, and other emerging nicotine delivery systems. This expansion marks a departure from the directive’s historical focus primarily on combustible tobacco products, acknowledging the shifting landscape of nicotine consumption.
Under the new proposal, specific minimum excise duty rates are slated for these newly included products. For nicotine pouches and other non-combustible nicotine products, the Council proposal introduces a minimum tax rate of 10 percent of the retail selling price or €30 per kilogram, whichever is greater, to be implemented between 2028 and 2029. This is then set to transition to a more substantial 25 percent minimum or €50 per kilogram from 2030 to 2031, before ultimately reaching a formidable 50 percent minimum or €80 per kilogram. Simultaneously, the proposal seeks to increase the minimum excise tax on traditional cigarettes to 60 percent of the weighted average retail selling price or €200 per 1,000 cigarettes, with certain transitional provisions designed to ease the adjustment for Member States. These proposed rates are seen by many as more than a simple attempt to curb tax arbitrage; they represent a bold, European-wide judgment on the appropriate level of taxation for consumers of selected nicotine products, effectively setting a harmonized price floor across the bloc.
Historical Context of the Tobacco Excise Directive
The original Tobacco Excise Directive, established in 1992 (Directive 92/79/EEC, 92/80/EEC, and 95/59/EC, later consolidated), was conceived to harmonize excise duties on manufactured tobacco, primarily cigarettes, cigars, and smoking tobacco. Its core objective was to prevent significant distortions of competition within the nascent Single Market that could arise from vastly different national tax rates. The premise was that widely disparate prices could encourage cross-border shopping and illicit trade, thereby undermining national revenues and market integrity. The directive set minimum excise duty rates, allowing Member States the flexibility to impose higher rates according to their national fiscal and public health priorities. The last significant update to this framework occurred in 2011, long before the widespread adoption and diversification of products like e-cigarettes and heated tobacco.
The current impetus for revision stems from several factors. Firstly, the fragmentation of the nicotine market, with a proliferation of novel products, has created a patchwork of national regulatory and taxation approaches. Some Member States apply excise duties to these new products, while others do not, leading to what the EC views as competitive distortions. Secondly, the EC points to the need to align the directive with the EU’s broader public health objectives, particularly those outlined in "Europe’s Beating Cancer Plan," which aims to reduce tobacco use significantly. Thirdly, there is a recognized need to update the directive to reflect current market realities and combat illicit trade more effectively.
The EU’s Competence Conundrum: Taxation and Health
The European Union operates under the principle of conferred powers, meaning it can only act within the competences explicitly attributed to it by its Member States in the Treaties. Famously, direct taxation is not among these explicit competences. However, the Treaties do allow the EU to issue directives that aim to eliminate obstacles to the Single Market or distortions of competition, even if these arise from divergent national tax laws. This legal avenue has been the primary justification for previous excise duty harmonizations.
Conversely, the EU’s powers concerning health protection are more ambiguous. While Article 168 of the Treaty on the Functioning of the European Union (TFEU) mandates a high level of health protection in all Union policies and activities, it primarily grants the EU competence to complement national policies, encourage cooperation, and support Member State actions. It explicitly states that "Union action shall respect the responsibilities of the Member States for the definition of their health policy and for the organization and delivery of health services and medical care." Critically, it also prohibits harmonization of national laws in tobacco-related areas concerning health, a restriction often cited in legal challenges. Despite this prohibition, the EU has historically circumvented it by framing tobacco-related directives, such as those regulating tobacco advertising or product standards, as Single Market measures designed to prevent trade barriers.
In the context of the TED recast proposal, a pivotal question emerges: does the pendulum of justification swing more towards safeguarding the Single Market or towards advancing health protection? By establishing new minimum excise duty rates for an expanded range of products, the directive appears to lean heavily into a social policy objective—public health—while using the Single Market as the legal hook. This tension highlights the ongoing struggle to define the precise boundaries of EU intervention in areas where national sovereignty is fiercely guarded.
National Sovereignty and Divergent Realities
The intrinsic link between taxation, national budgets, and political accountability cannot be overstated. Even the EC acknowledges that Member States retain primary responsibility for tax collection and policy within their borders. This does not imply that every national tax policy is sacrosanct and immune to European coordination. However, it does underscore the imperative for the EU to exercise caution before replacing national policy choices with centralized rules, especially when the underlying policy problem is fundamentally domestic in nature.
Tobacco taxation serves as an exemplary case study. The 27 Member States of the EU are characterized by immense diversity: vastly different smoking rates, varying income levels, distinct healthcare systems, unique consumer preferences, and disparate enforcement capabilities. A tax rate deemed appropriate for a high-income, low-smoking-rate country like France, where illicit trade is already a significant concern due to high prices, may be wholly unsuitable for Bulgaria, a country with lower average incomes and different consumption patterns. Similarly, a tax rate that is easily administrable and enforceable in Germany, with its robust administrative structures, might prove considerably more challenging to implement in a country grappling with a larger informal economy or one sharing extensive borders with lower-taxed non-EU countries.
These profound differences underscore that Member States operate within distinct policy environments and often require a diverse toolkit of policy instruments to address their specific challenges effectively. A one-size-fits-all approach to tobacco taxation, particularly one that dictates minimum rates across such a heterogeneous bloc, risks creating unintended consequences, including increased illicit trade, reduced tax revenues, and suboptimal public health outcomes tailored to local needs.
Public Health or Fiscal Harmonization? The Debate Over Harm Reduction
The EC’s rationale for greater harmonization rests on a dual objective: protecting the integrity of the Single Market and advancing public health. Yet, the efficacy of the proposed measures in achieving both goals, particularly the latter, is subject to considerable debate. Currently, many Member States already impose excise rates significantly higher than the existing directive’s minimums. The wide divergence in these rates across the EU inherently undermines the directive’s stated harmonization goal, as national variations continue to be substantial. Furthermore, the outdated nature of the current directive means that novel products like e-cigarettes, heated tobacco, and nicotine pouches are taxed inconsistently across the bloc, with some Member States applying duties and others not.
A critical point of contention revolves around the potential impact of increasing taxes on less harmful nicotine products. Mainstream public health bodies, including Public Health England (now the UK Health Security Agency), have consistently found that e-cigarettes are significantly less harmful than combustible cigarettes—studies often cite a figure of around 95 percent less harmful. Economic research further suggests that imposing high taxes on these alternative tobacco products can inadvertently decrease the rate at which smokers switch away from more dangerous combustible cigarettes. This phenomenon, known as "substitution effect," suggests that if the price differential between traditional cigarettes and harm-reduced alternatives narrows due to increased taxes on the latter, fewer smokers will be incentivized to make the switch, potentially hindering public health progress.
The proposed minimum excise taxes on nicotine pouches and other non-combustible nicotine products exemplify this concern. The rapid escalation of minimum rates—from 10% or €30/kg in 2028-2029 to 50% or €80/kg by 2030-2031—represents a substantial fiscal burden on products widely considered to be significantly safer than cigarettes. If Member States conclude that maintaining a substantial price difference between highly harmful cigarettes and lower-risk nicotine products is a vital strategy to encourage smokers to transition away from combustible tobacco, then those governments should retain meaningful authority to pursue such an evidence-based public health strategy. The EU, through its harmonization efforts, should not inadvertently or intentionally make such harm reduction more difficult.
Harmonization in service of a policy that appears to contradict evidence-based approaches adopted at the Member State level risks being perceived as an exercise in paternalism rather than a genuine effort to foster public health. Centralized decision-making, in this context, could inadvertently threaten Member States’ ability to leverage effective policy tools to both raise revenue and, crucially, reduce harm within their populations. The EC’s own proposal acknowledges the diverse national approaches to products that substitute for combustible tobacco but justifies the new and higher taxes by arguing that these differences "distort competition" and undermine the Single Market. However, this justification overlooks the potential for negative public health consequences stemming from increased prices on harm-reduction products.
The Shadow Economy: Illicit Trade Concerns
The debate around tobacco taxation cannot ignore the pervasive issue of illicit trade. The EC should also consider that harmonization works both ways. Perhaps the problem isn’t solely that some countries maintain comparatively low and more equitable taxes on certain products, but rather that some countries have imposed tax rates that are excessively high, pushing consumption into illicit channels and beyond established EU norms.
France presents a stark illustration of this challenge. Despite having some of the highest cigarette taxes in the EU, nearly four in ten packs of cigarettes consumed in France are not purchased legally within the country. This staggering figure underscores a critical question: is the problem observed in France a result of cigarette tax rates being too low in other EU countries, or are they simply too high within France itself, making legal products prohibitively expensive and fueling a lucrative black market? If tax-induced smuggling demonstrably fuels illicit markets, deprives national treasuries of revenue, and potentially harms public health by providing unregulated products, it would certainly be valid for other Member States to demand that limits be placed not only on minimum tax rates but also on excessively high maximum rates. The revised TED, by potentially raising minimums without addressing the upper limits or the dynamics of illicit trade, might exacerbate existing problems in high-tax countries while creating new ones in others.
The Swedish Exception: A Model for Harm Reduction?
Perhaps the most significant challenge to an increasingly centralized approach to tobacco taxation is its tendency to treat all nicotine products, and their taxation, as though they carry identical policy implications. This oversight is particularly problematic because the preferred policy blueprint emanating from Brussels may not align with strategies proven to most effectively reduce smoking rates.
Consider the compelling case of Sweden. Sweden’s experience with tobacco and nicotine consumption stands in stark contrast to that of most other European countries. Remarkably, Sweden boasts the lowest smoking rate of any EU Member State. The Swedish Public Health Agency reported in 2024 that only 5.4 percent of adults aged 16-84 smoked daily, a dramatic reduction from approximately 14 percent in 2006. This remarkable outcome, often referred to as the "Swedish Experience," should prompt countries globally to examine and potentially emulate its policy framework. Yet, current EU policymakers appear to be advocating for a diametrically opposite policy approach.
Sweden has a rich history of producing and consuming snus, a smokeless oral tobacco product. This long-standing cultural acceptance and domestic production base positioned Swedish companies to lead innovation in the development of modern smokeless oral pouches, which are entirely tobacco-free but contain nicotine. These modern oral pouches have witnessed a rapid surge in global demand and have played a significant role in the decline of combustible smoking rates in Sweden and other markets.
Despite the incredible potential for harm reduction offered by nicotine pouches—public filings with regulatory bodies like the U.S. FDA have demonstrated that these products are remarkably safer for consumers than combustible cigarettes—they remain banned in several EU countries, including France, Belgium, and the Netherlands. This prohibition, coupled with the proposed punitive taxation under the revised TED, raises a seemingly obvious policy question: why isn’t the EU actively seeking to replicate Sweden’s successful tobacco policy, which emphasizes the legal availability and appropriate taxation of less harmful products across the bloc? At the very least, the EU should refrain from ignoring or actively undermining demonstrably successful policies that have led to significant reductions in smoking rates. The fundamental goal of the TED should be to ensure a functioning Single Market, not to impose a singular, potentially counterproductive, European tobacco policy.
Stakeholder Reactions and Broader Implications
The proposed TED revision is expected to elicit varied reactions from a broad spectrum of stakeholders. Member States with traditionally lower excise duties on novel products or those with strong harm reduction strategies, like Sweden, are likely to voice concerns about the erosion of their national policy autonomy and the potential negative impact on public health initiatives. Conversely, Member States that already impose high taxes on these products, or those with more prohibitionist stances, might welcome the harmonization as a means to level the playing field or reinforce their public health objectives.
Industry players, particularly manufacturers of e-cigarettes, heated tobacco, and nicotine pouches, are expected to lobby against the higher minimum taxes, arguing that they stifle innovation, reduce consumer choice, and ultimately harm public health by discouraging switching from combustible cigarettes. Consumer advocacy groups, especially those focused on harm reduction, will likely echo these concerns, emphasizing the disproportionate impact on adult smokers seeking safer alternatives. Traditional tobacco companies, on the other hand, might see certain aspects of the directive as beneficial, particularly if it reduces the competitive advantage of novel products.
Public health organizations are likely to be split. While some will support any measure perceived to reduce overall nicotine consumption, others, particularly those advocating for harm reduction, might express reservations about taxing less harmful products at rates that disincentivize their use as alternatives to smoking. The World Health Organization (WHO), for instance, has often taken a cautious stance on novel nicotine products, advocating for their regulation and taxation, but the specific rates and their impact on substitution remain a contentious area.
The broader implications of this TED revision extend beyond tobacco products. It serves as a significant test case for the principle of subsidiarity—the idea that decisions should be taken at the lowest possible level of governance—within the EU. If the EU is perceived to be overstepping its bounds in an area as sensitive as national taxation and public health strategy, it could set a precedent for future interventions in other policy domains where national sovereignty is highly valued. It also raises questions about the EU’s approach to innovation and market development, particularly in sectors where new products offer potential public health benefits. Finding a judicious balance between harmonizing the Single Market and respecting the diverse national contexts and public health strategies of its Member States will be crucial for the legitimacy and effectiveness of EU action in the years to come. The goal should be to facilitate trade and reduce harm, not to impose a rigid uniformity that overlooks national successes and unintended consequences.
